Clinical Trials on Prostate and Kidney Cancer in Germany
Total 2935 results
-
Association of Urologic Oncology (AUO)Terminated
-
Life Molecular Imaging SACompleted
-
Novartis PharmaceuticalsCompleted
-
University of Erlangen-Nürnberg Medical SchoolUnknown
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Profound Medical Inc.CompletedProstate CancerUnited States, Canada, Germany
-
Martini-Klinik am UKE GmbHUniversity Hospital Hamburg, Institute of Tumor BiologyRecruitingProstate CancerGermany
-
Prof. Dr. med. Christian GratzkeMerck Sharp & Dohme LLCRecruitingUrologic Cancer | Biochemical Recurrence of Malignant Neoplasm of ProstateGermany
-
GlaxoSmithKlineCompletedNeoplasms, Prostate | Prostate Cancer After a Radical TreatmentSpain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
-
Universität des SaarlandesCompletedBenign Prostatic Hyperplasia | Primary Prostate Urothelial CancerGermany
-
Aesculap AGCompletedKidney Cancer | Nephrolithiasis | Prostate Cancer | Nephritis | Kidney Injury | Hydronephrosis | Congenital Abnormality of Kidney | Kidney TuberculosisGermany
-
Merck KGaA, Darmstadt, GermanyCompletedProstate Cancer | Bone MetastasesBelgium, Germany
-
University Hospital HeidelbergRecruitingProstate CancerGermany
-
University Hospital HeidelbergLudwig-Maximilians - University of Munich; University Hospital, ZürichActive, not recruitingProstate CancerGermany
-
Paracelsus Medical UniversityCompletedProstate CancerGermany
-
University Hospital, BonnPhilips HealthcareCompletedProstate Cancer | Multiparametric MRIGermany
-
Advanced Medical Diagnostics s.a.CompletedProstate CancerGermany, United Kingdom, Belgium, Czech Republic, Hungary
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
NovartisCompleted
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
University Hospital, BonnCompleted
-
Technical University of MunichUnknownProstate CancerGermany
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
Astellas Pharma IncMedivation, Inc.CompletedProstate CancerBelgium, Czechia, Denmark, Germany
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Ferring PharmaceuticalsCompleted
-
University Hospital FreiburgGerman Federal Ministry of Education and ResearchRecruiting
-
Ludwig Institute for Cancer ResearchCompletedProstate CancerSwitzerland, Germany
-
University Hospital, EssenRecruitingProstate Cancer | Survivorship | PET/CT | PSMAGermany
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
University of LeipzigHeinrich-Heine University, Duesseldorf; University Hospital Heidelberg; Klinikum...Completed
-
Hoffmann-La RocheTerminatedProstate CancerSpain, United Kingdom, France, Germany, Italy, Netherlands
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Association of Urologic Oncology (AUO)Unknown
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Universität des SaarlandesCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Radboud University Medical CenterJohns Hopkins University; University Health Network, Toronto; Medical University... and other collaboratorsCompletedProstate CancerUnited States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
-
Bracco Diagnostics, IncBracco Imaging S.p.A.TerminatedProstate CancerItaly, Austria, France, Netherlands, Belgium, Germany, United Kingdom
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
IpsenCompleted
-
Eli Lilly and CompanyCompletedProstate CancerSpain, Poland, Germany, United States
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Jena University HospitalUniversity Hospital Schleswig-Holstein; Klinikum StuttgartNot yet recruitingQuality of Life | Prostate Cancer | Adaptive RadiotherapyGermany